How many institutions held BLRX - BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share in Q4 2019?

9 institutional investors reported BLRX - BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share for Q4 2019. Use the holders table for investor-level position and value details.

BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX)

Q: What does CUSIP 09071M205 represent in this 13F holders report?

CUSIP 09071M205 is the security identifier for BLRX - BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share used to aggregate holder disclosures.

CUSIP: 09071M205

Q4 2019 13F Holders as of 31 Dec 2019

Security type / class: Equity / Ordinary shares, par value NIS 0.10 per share
Total 13F shares: 2,713,411
Total 13F value: $6,106,029
Share change: +200,039
SEC-reported price per share: $2.25
Number of holders: 9
Value change: +$432,144
Number of buys: 4
Number of sells: 5
Shares outstanding: 2,048,819,940

Security key

09071M205

Report period

Q4 2019

Institutions

Top holders

BLRX full security history Ownership snapshot Full 13F holder table BioLineRx Ltd. SEC filings BioLineRx Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BLRX - BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BVF INC/IL

Disclosed value leader

BVF INC/IL

Comparable rows

12/14

Latest evidence

30 Sep 2019

13F Lead comparable stake: 0.08% 2 rows are not safely comparable across share classes. Showing 1-6 of 14 holder rows.

Quick read

BVF INC/IL leads the comparable SEC ownership view at 0.08%.

12 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BVF INC/IL's linked filing trail.

Comparable ownership Top 5

BVF INC/IL 0.08%

Senvest Management, LLC 0.02%

MORGAN STANLEY 0.01%

ORBIMED ADVISORS LLC 0%

ETF MANAGERS GROUP, LLC 0%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 14 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BVF INC/IL	13F Company 13F	0.08%	$4,575,000 1,733,036 shares	—	30 Sep 2019
Senvest Management, LLC	13F Company 13F	0.02%	$1,327,000 502,587 shares	—	30 Sep 2019
MORGAN STANLEY	13F Company 13F	0.01%	$384,000 145,382 shares	—	30 Sep 2019
ORBIMED ADVISORS LLC	13F Company 13F	0%	$183,000 69,240 shares	—	30 Sep 2019
ETF MANAGERS GROUP, LLC	13F Company 13F	0%	$123,000 47,745 shares	—	30 Sep 2019
NEXT Financial Group, Inc	13F Company 13F	0%	$20,000 7,530 shares	—	30 Sep 2019

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

2,713,411

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 holders

Q4 2019 holders

Holder diff

-2

Investor	Q3 2019 Shares	Q4 2019 Shares	Share Diff	Share Chg %	Q3 2019 value	Q4 2019 value	Value change	Value Chg %